E A Stolk1, J J Busschbach, T Vogels. 1. Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam. stolk@bmg.eur.nl
Abstract
OBJECTIVE: To investigate the feasibility and validity of a proxy version of the EuroQol in children treated for imperforate anus. METHODS: Patients included were between 1 and 51 years of age. Instruments included were the EuroQol, the TACQOL and a disease specific questionnaire, the Langemeijer Stool Questionnaire. Patients older than 15 years filled in all questionnaires themselves, in the age groups 5-10 and 11-15 a parent administered the questionnaires. Feasibility was judged on the number of missing values. In search of validity, EuroQol scores were compared with the prevalence of disease symptoms (convergent validity) and with the TACQOL (construct validity). RESULTS: The number of missings was not related to age. The disease specific questionnaire correlated significantly with the EQvas from 11 years on and with the EQ-5Dindex from 5 years on. The mean correlation between contextual similar domains of the EuroQol and the TACQOL was -0.55. The correlation between different domains was -0.32. CONCLUSION: The results support the idea that the use of a proxy version of the EuroQol is feasible and valid. The convergent validity of the EQvas was supported from 11 years on. The EQ-5D showed good construct and convergent validity from 5 years on.
OBJECTIVE: To investigate the feasibility and validity of a proxy version of the EuroQol in children treated for imperforate anus. METHODS:Patients included were between 1 and 51 years of age. Instruments included were the EuroQol, the TACQOL and a disease specific questionnaire, the Langemeijer Stool Questionnaire. Patients older than 15 years filled in all questionnaires themselves, in the age groups 5-10 and 11-15 a parent administered the questionnaires. Feasibility was judged on the number of missing values. In search of validity, EuroQol scores were compared with the prevalence of disease symptoms (convergent validity) and with the TACQOL (construct validity). RESULTS: The number of missings was not related to age. The disease specific questionnaire correlated significantly with the EQvas from 11 years on and with the EQ-5Dindex from 5 years on. The mean correlation between contextual similar domains of the EuroQol and the TACQOL was -0.55. The correlation between different domains was -0.32. CONCLUSION: The results support the idea that the use of a proxy version of the EuroQol is feasible and valid. The convergent validity of the EQvas was supported from 11 years on. The EQ-5D showed good construct and convergent validity from 5 years on.
Authors: N C Theunissen; T G Vogels; H M Koopman; G H Verrips; K A Zwinderman; S P Verloove-Vanhorick; J M Wit Journal: Qual Life Res Date: 1998-07 Impact factor: 4.147
Authors: T Vogels; G H Verrips; S P Verloove-Vanhorick; M Fekkes; R P Kamphuis; H M Koopman; N C Theunissen; J M Wit Journal: Qual Life Res Date: 1998-07 Impact factor: 4.147
Authors: Marten J Poley; Werner B F Brouwer; Jan J V Busschbach; Frans W J Hazebroek; Dick Tibboel; Frans F H Rutten; Jan C Molenaar Journal: Pediatr Surg Int Date: 2007-11-06 Impact factor: 1.827
Authors: Karine Chevreul; Morgane Michel; Karen Berg Brigham; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Ulf Persson; Giovani Fattore Journal: Eur J Health Econ Date: 2016-04-08
Authors: M Kamphuis; J Ottenkamp; H W Vliegen; T Vogels; K H Zwinderman; R P Kamphuis; S P Verloove-Vanhorick Journal: Heart Date: 2002-04 Impact factor: 5.994
Authors: Andrea Berkes; István Pataki; Mariann Kiss; Csilla Kemény; László Kardos; James W Varni; Gábor Mogyorósy Journal: Health Qual Life Outcomes Date: 2010-01-28 Impact factor: 3.186